Obesity causes serious diseases such as cardiovascular disease, cancer, diabetes, osteoarthritis, and chronic kidney disease. If left untreated, obesity can lead to future decline in life expectancy.
During the past few years, obesity has become a matter of great concern in Pakistan. In 2013, 28 percent of men and 38 percent of women were overweight but now the situation is even worse. According to a recent survey published in “The Lancet” in 2014, one third of adults in Pakistan are overweight.
OBS Pakistan (Pvt.) Ltd has always been focusing to provide quality health care solutions to improve the wellbeing of the nation. Considering these alarming facts, OBS Pakistan (Pvt.) Ltd, has launched an effective anti obesity drug, Orlirise (Orlistat 120mg) capsule in Pakistan. Orlirise blocks the absorption of dietary fat in the body without causing any side effect and thus limits the dietary intake of fats.
On September 9 & 10, 2014 successful launch sessions were conducted at Dream World Resorts Karachi by CV-2 team. These sessions included product and disease training to the sales team on which launch strategies were based upon. During these sessions, team participated with great confidence and found these sessions helpful to add value. The launch session ended up with an energetic and participative detailing competition followed by cake cutting by Managing Director Dr. Ali Afzal. The whole team was enthusiastic and was committed to make it a successful brand by delivering organizational objectives. Right after the internal launch, external launch programs were introduced by sales and marketing department in all over Pakistan.
Orlirise is not only a great addition to the corporate portfolio, but it will also prove to be a life style modifier for the people of Pakistan.